Pharmacokinetics and toxicology of therapeutic proteins: Advances and challenges.

World Journal of Biological Chemistry
Yulia VugmeysterMichael W Leach

Abstract

Significant progress has been made in understanding pharmacokinetics (PK), pharmacodynamics (PD), as well as toxicity profiles of therapeutic proteins in animals and humans, which have been in commercial development for more than three decades. However, in the PK arena, many fundamental questions remain to be resolved. Investigative and bioanalytical tools need to be established to improve the translation of PK data from animals to humans, and from in vitro assays to in vivo readouts, which would ultimately lead to a higher success rate in drug development. In toxicology, it is known, in general, what studies are needed to safely develop therapeutic proteins, and what studies do not provide relevant information. One of the major complicating factors in nonclinical and clinical programs for therapeutic proteins is the impact of immunogenicity. In this review, we will highlight the emerging science and technology, as well as the challenges around the pharmacokinetic- and safety-related issues in drug development of mAbs and other therapeutic proteins.

Citations

Apr 16, 2013·European Journal of Drug Metabolism and Pharmacokinetics·Rajan Swami, Aliasgar Shahiwala
Nov 24, 2012·Bioanalysis·Hendrik NeubertEric Fluhler
Feb 22, 2013·Bioanalysis·Anita O'Connor, Mark Rogge
May 21, 2014·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Melody Sauerborn, William van Dongen
Aug 16, 2014·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Daniel SchweizerAchim Goepferich
Nov 5, 2013·Bioanalysis·Denise M O'Hara, Valerie Theobald
Nov 12, 2014·Postgraduate Medicine·Malcolm A YoungRickey R Reinhardt
Jun 5, 2014·Expert Opinion on Drug Metabolism & Toxicology·Eric EzanFrançois Fenaille
Nov 29, 2013·Journal of Pharmaceutical Sciences·Benjamin Wu, Yu-Nien Sun
Mar 20, 2013·Journal of Pharmaceutical Sciences·Leijun Hu, Ryan J Hansen
Jun 26, 2015·Journal of Pharmaceutical Sciences·Sahar AwwadPeng T Khaw
Feb 13, 2016·Journal of Pharmaceutical Sciences·Liang JinJoseph A Nicolazzo
Jan 29, 2016·Clinical Pharmacokinetics·Katherine L GillManoranjenni Chetty
Dec 3, 2014·Journal of Immunological Methods·Piotr PierogBinodh DeSilva
Oct 3, 2015·MAbs·Terrence L FisherMaurice Zauderer
Apr 2, 2014·Chemical Biology & Drug Design·Sara HosseininasabSoodabeh Davaran
Apr 16, 2016·Journal of Proteomics·Elena MaestriNelson Marmiroli
Aug 15, 2013·Drug Discovery Today·Sven KronenbergThomas Singer
Dec 4, 2013·International Immunopharmacology·Yulia VugmeysterSheldon S Leung
Nov 30, 2013·Journal of Immunological Methods·Martin SchwickartMeina Liang
Apr 24, 2014·Computational and Structural Biotechnology Journal·Remko van VughtEefjan Breukink
Mar 3, 2015·European Journal of Drug Metabolism and Pharmacokinetics·Byung-Yo LeeIn-Hwan Baek
May 18, 2016·The Journal of Clinical Investigation·Erez M BublilJan P Kraus
May 29, 2016·Regulatory Toxicology and Pharmacology : RTP·Janet GouldPatricia A Weideman
May 29, 2016·Regulatory Toxicology and Pharmacology : RTP·Joel P BercuPatricia A Weideman
Jun 12, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Susanne BeyerMatthias G Wacker
Jun 24, 2016·Biotechnology Letters·Ray Bakhtiar
Jul 21, 2016·Journal of Immunology Research·Anshu KuriakosePradip Nair
May 22, 2013·International Journal of Cell Biology·Xiaotian Zhong, Jill F Wright

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.